Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (281-290 of 460) with videos related to

Pageof 46
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domainsCarmine Carpenito, Michael C Milone, Raffit Hassan, et al.
Blood|August 4, 2016
miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potencyYunjie Lu, Keli L Hippen, Amanda L Lemire, et al.
The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2024
IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translationCaitlin M Tilsed, Barzan A Sadiq, Tyler E Papp, et al.
Blood|June 24, 2010
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemiaQing Zhou, Meghan E Munger, Steven L Highfill, et al.
Blood Cancer Discovery|August 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in MyelomaKavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal, et al.
Blood|September 27, 2019
CAR T cell viability release testing and clinical outcomes: is there a lower limit?Elise A Chong, Bruce L Levine, Stephan A Grupp, et al.
Science Translational Medicine|December 3, 2011
The PDL1-PD1 axis converts human TH1 cells into regulatory T cellsShoba Amarnath, Courtney W Mangus, James C M Wang, et al.
Immunity|August 27, 2017
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsOmkar U Kawalekar, Roddy S O' Connor, Joseph A Fraietta, et al.
JCI Insight|December 6, 2019
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cellYanran He, Karin Schreiber, Steven P Wolf, et al.
Pageof 46

Showing results (281-290 of 460) with videos related to

Sort By:
Pageof 46
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domainsCarmine Carpenito, Michael C Milone, Raffit Hassan, et al.
Blood|August 4, 2016
miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potencyYunjie Lu, Keli L Hippen, Amanda L Lemire, et al.
The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2024
IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translationCaitlin M Tilsed, Barzan A Sadiq, Tyler E Papp, et al.
Blood|June 24, 2010
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemiaQing Zhou, Meghan E Munger, Steven L Highfill, et al.
Blood Cancer Discovery|August 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in MyelomaKavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal, et al.
Blood|September 27, 2019
CAR T cell viability release testing and clinical outcomes: is there a lower limit?Elise A Chong, Bruce L Levine, Stephan A Grupp, et al.
Science Translational Medicine|December 3, 2011
The PDL1-PD1 axis converts human TH1 cells into regulatory T cellsShoba Amarnath, Courtney W Mangus, James C M Wang, et al.
Immunity|August 27, 2017
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T CellsOmkar U Kawalekar, Roddy S O' Connor, Joseph A Fraietta, et al.
JCI Insight|December 6, 2019
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cellYanran He, Karin Schreiber, Steven P Wolf, et al.
Pageof 46